Janice Ely
Obstetrics & Gynecology · Jacksonville, FLNPI 1700800513
Payments from drug & device makers
Across 119 payments — averaging $17.15 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Astellas Pharma US Inc$290
- AbbVie$206
- Novo Nordisk$196
- Mayne Pharma Commercial LLC$188
- Hologic Sales And Service, LLC$186
- Therapeuticsmd, Inc.$149
- plus $825 from 17 others
What the payments were for
- Food & beverage$1,94195%
- Education$1005%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Astellas Pharma US Inc | 11 | $290 |
| AbbVie | 14 | $206 |
| Novo Nordisk | 11 | $196 |
| Mayne Pharma Commercial LLC | 12 | $188 |
| Hologic Sales And Service, LLC | 10 | $186 |
| Therapeuticsmd, Inc. | 11 | $149 |
| Daiichi Sankyo Inc. | 8 | $132 |
| Pfizer | 7 | $114 |
| Agile Therapeutics, Inc. | 5 | $84 |
| Bayer | 5 | $73 |
| Scynexis, Inc. | 4 | $57 |
| Myovant Sciences Inc. | 3 | $47 |
| Shield Therapeutics Inc | 2 | $46 |
| Avion Pharmaceuticals | 3 | $43 |
| Exeltis, USA Inc. | 2 | $38 |
| Sage Therapeutics, LLC | 2 | $37 |
| Vivus LLC | 2 | $31 |
| Virtus Pharmaceuticals LLC | 2 | $30 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $24 |
| Evofem Biosciences, Inc. | 1 | $24 |
| Biohaven Pharmaceuticals, Inc. | 1 | $18 |
| Merck | 1 | $16 |
| Roche Diagnostics Corporation | 1 | $12 |
How this compares
$2,041 in reported general payments places this provider in the 70th percentile of 2,438 obstetrics & gynecology providers in Florida.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Estradiol | 51 | $1,512 |
| ProgesteroneProgesterone, Micronized | 37 | $1,275 |
| Fluconazole | 14 | $71 |
| Alprazolam | 11 | $57 |
Paid to pharmacies, not to this prescriber.
Other obstetrics & gynecology in Jacksonville
- Richard MyersJacksonville$2.7M
- Andrew KaunitzJacksonville$202K
- Samuel LedermanLake Worth$13.4M
- Guillermo LievanoMiami$2.5M
- Steven McCarusCelebration$2.3M
- Samuel WolfPanama City$2.1M
- Rafael Garcia-OcasioHialeah$2M
- Douglas MoffettLeesburg$1.7M
- Harvey GlasserAventura$1.6M
- Jorge PandoMiami Lakes$1.5M
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.